text: MERCK RECEIVES APPROVABLE LETTER FOR ARCOXIA; EMPHASIZES ITS &lt;b&gt;...&lt;/b&gt; On the same day that Merck  amp; Co. Inc. announced its receipt of an approvable letter from the Food and Drug Administration for use of Arcoxia (etoricoxib) in several inflammatory conditions, the company said 